Breaking News Instant updates and real-time market news.

GWPH

GW Pharmaceuticals

$115.82

-0.37 (-0.32%)

08:02
04/21/17
04/21
08:02
04/21/17
08:02

GW Pharmaceuticals initiated with a Buy at Maxim

Maxim analyst Lauren Chung initiated GW Pharmaceuticals with a Buy rating and $135 price target, calling the company the "market leader" in cannabis therapeutics with a first-mover advantage in epilepsy.

GWPH GW Pharmaceuticals
$115.82

-0.37 (-0.32%)

03/02/17
JANY
03/02/17
NO CHANGE
Target $55
JANY
Sell
GW Pharmaceuticals expectations, valuation remain too high, says Janney Capital
Janney Capital analyst Ken Trbovich raised his estimates for GW Pharmaceuticals and increased his fair value estimate for the shares to $55, citing the "excitement" he heard among physicians who regularly treat patients with Epidiolex during the Annual Epilepsy Society meeting last December. However, he continues to think regulatory and commercial challenges will likely prevent Epidiolex from achieving high expectations set by the market, even if the drug is approved on first review for Dravet Syndrome and LGS and the subsequent studies in infantile spasm and tuberous sclerosis succeed. Trbovich, who notes that consensus estimates call for Epidiolex to hit $900M in sales in just 3-4 years even though the most recent FDA-approved drugs for orphan epilepsy indications had sales in the range of $100M-$300M 4-8 years after launch, keeps a Sell rating on GW shares.
02/07/17
PIPR
02/07/17
NO CHANGE
Target $147
PIPR
Overweight
Piper says GW Pharmaceuticals remains on track with Epidiolex
Piper Jaffray analyst Joshua Schimmer said GW Pharmaceuticals remains on track to potentially launch Epidiolex for Dravet Syndrome and LGS in the first half of 2018 and he sees the company's expanded access program and ongoing trials positioning the product for a "robust launch" upon approval. Retention of patients on therapy remains "exceptionally high," added the analyst, who calls GW a top mid-cap pick citing his confidence in the commercial outlook for Epidiolex and optimism about its pipeline. Schimmer keeps an Overweight rating and $147 price target on GW Pharma shares.
02/07/17
CANT
02/07/17
NO CHANGE
Target $208
CANT
Overweight
GW Pharmaceuticals Phase 2 data 'very encouraging,' says Cantor
Cantor Fitzgerald analyst Elemer Piros believes GW Pharmaceuticals' Phase 2 glioblastoma multiforme data today are "very encouraging" and further support of the "multi-potent effect of cannabinoid-based medicines across an array of neurological condition." The analyst reiterates a Buy rating on GW shares with a $208 price target. The stock in early trading is up 93c to $121.69.
12/05/16
CANT
12/05/16
NO CHANGE
Target $208
CANT
Buy
GW Pharmaceuticals price target raised after Epidiolex data at Cantor
Cantor analyst Elemer Piros raised his price target for GW Pharmaceuticals to $208 from $182 following its Epidiolex data presented at the American Epilepsy Society meeting. The analyst believes the data illustrates "robustness and remarkable consistency" across two distinct forms of epilepsy, Lennox Gastaut and Dravet syndrome and notes that the company laid to rest the largely overblown concern regarding drug interaction with clobazam. Piros believes GW Pharmaceuticals is in "good shape" for a New Drug Application covering both indications by the end of 1H17, and reiterates a Buy rating on the shares.

TODAY'S FREE FLY STORIES

MHK

Mohawk

$242.70

-0.22 (-0.09%)

19:27
06/22/17
06/22
19:27
06/22/17
19:27
Initiation
Mohawk initiated  »

Mohawk initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBHS

Fortune Brands

$65.09

0.06 (0.09%)

19:27
06/22/17
06/22
19:27
06/22/17
19:27
Initiation
Fortune Brands initiated  »

Fortune Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

JELD-WEN Holding

$34.60

-0.29 (-0.83%)

19:26
06/22/17
06/22
19:26
06/22/17
19:26
Initiation
JELD-WEN Holding initiated  »

JELD-WEN Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBP

Installed Building Products

$52.75

-1 (-1.86%)

19:26
06/22/17
06/22
19:26
06/22/17
19:26
Initiation
Installed Building Products initiated  »

Installed Building…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OC

Owens Corning

$66.42

-0.85 (-1.26%)

19:26
06/22/17
06/22
19:26
06/22/17
19:26
Initiation
Owens Corning initiated  »

Owens Corning initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WHR

Whirlpool

$195.16

1.35 (0.70%)

19:26
06/22/17
06/22
19:26
06/22/17
19:26
Initiation
Whirlpool initiated  »

Whirlpool initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAS

Masco

$38.82

0.06 (0.15%)

19:26
06/22/17
06/22
19:26
06/22/17
19:26
Initiation
Masco initiated  »

Masco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEG

Leggett & Platt

$52.66

-0.16 (-0.30%)

19:26
06/22/17
06/22
19:26
06/22/17
19:26
Initiation
Leggett & Platt initiated  »

Leggett & Platt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USG

USG

$29.29

0.35 (1.21%)

19:26
06/22/17
06/22
19:26
06/22/17
19:26
Initiation
USG initiated  »

USG initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSTE

Caesarstone

$35.20

1.05 (3.07%)

19:26
06/22/17
06/22
19:26
06/22/17
19:26
Initiation
Caesarstone initiated  »

Caesarstone initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$957.09

-2.36 (-0.25%)

, GOOGL

Alphabet Class A

$976.62

-1.97 (-0.20%)

19:18
06/22/17
06/22
19:18
06/22/17
19:18
Hot Stocks
YouTube says reaches 1.5B monthly users »

In a blog post Thursday,…

GOOG

Alphabet

$957.09

-2.36 (-0.25%)

GOOGL

Alphabet Class A

$976.62

-1.97 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

AHH

Armada Hoffler

$13.70

-0.07 (-0.51%)

19:08
06/22/17
06/22
19:08
06/22/17
19:08
Downgrade
Armada Hoffler rating change  »

Armada Hoffler downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

SBUX

Starbucks

$59.51

-0.45 (-0.75%)

18:59
06/22/17
06/22
18:59
06/22/17
18:59
Initiation
Starbucks initiated  »

Starbucks initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

GPMT

Granite Point Mortgage

18:16
06/22/17
06/22
18:16
06/22/17
18:16
Syndicate
Granite Point Mortgage 10M share IPO priced at $19.50 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

TWO

Two Harbors

$10.39

0.02 (0.19%)

, GPMT

Granite Point Mortgage

18:15
06/22/17
06/22
18:15
06/22/17
18:15
Hot Stocks
Two Harbors to contribute commercial real estate assets to Granite Point »

Two Harbors Investment…

TWO

Two Harbors

$10.39

0.02 (0.19%)

GPMT

Granite Point Mortgage

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

GE

General Electric

$27.55

-0.23 (-0.83%)

18:05
06/22/17
06/22
18:05
06/22/17
18:05
Hot Stocks
Concept Laser, LAUAK sign LOI for additive manufacturing collaboration »

Concept Laser, a GE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 02

    Oct

BBBY

Bed Bath & Beyond

$33.74

0.08 (0.24%)

18:05
06/22/17
06/22
18:05
06/22/17
18:05
Hot Stocks
Breaking Hot Stocks news story on Bed Bath & Beyond »

Bed Bath & Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 29

    Jun

OKE

Oneok

$47.79

0.38 (0.80%)

, OKS

Oneok Partners

$46.94

0.44 (0.95%)

17:59
06/22/17
06/22
17:59
06/22/17
17:59
Hot Stocks
Oneok and Oneok Partners merger recommended by two proxy advisory firms »

Oneok (OKE) and Oneok…

OKE

Oneok

$47.79

0.38 (0.80%)

OKS

Oneok Partners

$46.94

0.44 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$27.55

-0.23 (-0.83%)

17:55
06/22/17
06/22
17:55
06/22/17
17:55
Conference/Events
Economic Club of New York to host a meeting »

The Economic Club of New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 02

    Oct

SGH

Smart Global

$16.20

0.45 (2.86%)

, IDRA

Idera Pharmaceuticals

$1.73

0.02 (1.17%)

17:52
06/22/17
06/22
17:52
06/22/17
17:52
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Smart…

SGH

Smart Global

$16.20

0.45 (2.86%)

IDRA

Idera Pharmaceuticals

$1.73

0.02 (1.17%)

BAC

Bank of America

$22.93

-0.2 (-0.86%)

BBBY

Bed Bath & Beyond

$33.74

0.08 (0.24%)

SONC

Sonic

$27.50

-0.02 (-0.07%)

AMSWA

American Software

$11.97

0.9 (8.13%)

OCUL

Ocular Therapeutix

$11.54

0.5 (4.53%)

PIR

Pier 1 Imports

$5.14

0.08 (1.58%)

WSM

Williams-Sonoma

$47.18

0.48 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 22

    Jun

  • 22

    Jun

  • 22

    Jun

  • 22

    Jun

  • 28

    Jun

  • 29

    Jun

  • 19

    Jul

BBBY

Bed Bath & Beyond

$33.74

0.08 (0.24%)

17:52
06/22/17
06/22
17:52
06/22/17
17:52
Hot Stocks
Breaking Hot Stocks news story on Bed Bath & Beyond »

Bed Bath & Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 29

    Jun

SUN

Sunoco

$30.11

0.69 (2.35%)

17:51
06/22/17
06/22
17:51
06/22/17
17:51
Hot Stocks
Sunoco CEO Bob Owens to retire, Joe Kim named COO »

Sunoco announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$86.34

3.78 (4.58%)

, TMO

Thermo Fisher

$175.47

-0.13 (-0.07%)

17:48
06/22/17
06/22
17:48
06/22/17
17:48
Hot Stocks
Novartis: FDA approves Tafinlar-Mekinist combo in non-small cell lung cancer »

Novartis (NVS) announced…

NVS

Novartis

$86.34

3.78 (4.58%)

TMO

Thermo Fisher

$175.47

-0.13 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 12

    Jul

TMO

Thermo Fisher

$175.47

-0.13 (-0.07%)

, LH

LabCorp

$150.34

4.13 (2.82%)

17:34
06/22/17
06/22
17:34
06/22/17
17:34
Hot Stocks
Thermo Fisher says FDA grants premarket approval for Oncomine Dx Target Test »

Thermo Fisher (TMO)…

TMO

Thermo Fisher

$175.47

-0.13 (-0.07%)

LH

LabCorp

$150.34

4.13 (2.82%)

NEO

NeoGenomics

$8.70

0.21 (2.47%)

CGIX

Cancer Genetics

NVS

Novartis

$86.34

3.78 (4.58%)

PFE

Pfizer

$34.06

0.18 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 26

    Jun

  • 11

    Jul

  • 12

    Jul

  • 02

    Aug

  • 27

    Aug

NGHC

National General

17:32
06/22/17
06/22
17:32
06/22/17
17:32
Syndicate
Breaking Syndicate news story on National General »

National General files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.